Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
New words:
ABP, adhesive, airport, alloy, antibody, AP, apportionment, attenuation, beta, biomarker, biotherapeutic, BPC, broader, cDNA, choice, climate, Cole, commonly, compensatory, corroborated, customizable, Danish, depth, desired, Dr, drift, dual, EDS, Edward, encompassing, exterior, fiber, fluid, forecasted, found, FTICR, fundamental, geology, geometrically, Gregory, hairpin, hardcopy, hardware, hassle, healing, Herrema, HR, hydrophobic, immunoassay, inflation, interfering, interferometric, interior, Ireland, iron, IVD, Judy, krone, landscape, leadership, led, Lewent, luminescence, match, medicinal, metabolomic, metallurgical, metallurgy, micro, modest, multi, multichannel, mutual, nanometer, nanotechnology, NIR, nonconvertible, nonforfeitable, nonrecurring, Observable, oligo, optoelectronic, oscillation, outlined, oxide, paired, Parmer, Parrett, PAT, peer, Pesicka, pesticide, pharmacokinetic, pilot, PIN, poor, preeminent, print, printed, prison, proactively, pronouncement, proteomic, purity, QC, qualitative, quantification, ray, reactive, recession, recurring, redundant, rollforward, safeguard, scattering, screw, sequence, shift, shRNA, silencing, silicon, siRNA, stable, streamline, submission, suspect, tapered, trial, Tsay, turbidity, twin, unobservable, Utah, vivo, WDS, weaker, William, worry, wound
Removed:
achieving, affordable, airborne, APCI, Appendix, Aquasil, arbitration, ARL, atmospheric, Autosampler, benzene, biochemical, borrow, borrowed, branding, bridge, Broadbent, campaign, capability, capable, ceased, charter, chemiluminescence, children, circulating, closure, Coleman, combustible, commenced, conform, consultancy, Cytocentrifuge, Darwin, defining, deoxyribonucleic, dependable, designated, device, dosage, dose, drawn, DSQ, dynamic, elderly, electrospray, eliminate, EMC, energy, ESD, ESI, Euribor, evaporating, expose, extrusion, family, FLIR, freeze, frequently, front, FT, generated, generating, Gold, governance, ground, Guy, hydrogen, hygiene, ICR, illicit, immersion, incorporating, Indenture, ineffective, integrating, interact, interchangeable, introduce, introducing, ionization, Jouan, KeyTek, LC, LCQ, LCs, Los, LTQ, lyophilize, mark, max, mercury, metabolic, Metrika, milestone, modeling, monoxide, MSn, negotiated, Nicolet, niton, nominating, nth, onset, operated, Optek, originally, ozone, Patashnick, pedestrian, PolarisQ, Police, polymerase, PPI, practical, pursue, Quantum, refinance, reorganization, repaid, reset, restriction, revising, rugged, Rupprecht, SampleManager, satisfaction, saving, Sentron, Shandon, signal, size, smaller, SOLA, spectroscopic, sterilizing, stop, sulfide, superior, survey, Surveyor, susceptible, tandem, trademark, Trex, TSQ, uniquely, unsafe, vehicle, versatile, versatility, warning, week, weighing, XL, young
Filing tables
Filing exhibits
- 10-K Annual report
- PDF PDF Version
- 10.14 Exhibit 10.14 (Severance Agreement)
- 10.27 Exhibit 10.27 (Annual Director Compensation)
- 10.43 Exhibit 10.43 (Amended and Restated 2005 Deferred Compensation Plan)
- 10.55 Exhibit 10.55 (Executive Change In Control Retention Agreement)
- 21 Exhibit 21 (Subsidiaries of the Registrant)
- 23.1 Exhibit 23.1 (Consent of Pricewaterhousecoopers LLP)
- 31.1 Exhibit 31.1 (Certification)
- 31.2 Exhibit 31.2 (Certification)
- 32.1 Exhibit 32.1 (Certification)
- 32.2 Exhibit 32.2 (Certification)
Related press release
TMO similar filings
Filing view
External links
Exhibit 32.1
CERTIFICATION REQUIRED BY EXCHANGE ACT RULES 13a-14(b) and 15d-14(b),
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report on Form 10-K of Thermo Fisher Scientific Inc. (the “Company”) for the period ended December 31, 2008 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, Marijn E. Dekkers, Chief Executive Officer of the Company, hereby certifies, pursuant to Securities Exchange Act of 1934 Rules 13a-14(b) and 15d-14(b), that:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: February 27, 2009
/s/ Marijn E. Dekkers | |
Marijn E. Dekkers President and Chief Executive Officer |
A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to Thermo Fisher Scientific Inc. and will be retained by Thermo Fisher Scientific Inc. and furnished to the Securities and Exchange Commission or its staff upon request.